Imunon, Inc. (IMNN) Stock Forecast
IMNN analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.75 / 5 from 4 analysts
- Price target
- $17.00 average of analyst targets
- Upside to target
- +1,566.7% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $-0.61
- 52-week range
- $1.02 – $5.05
IMNN analyst ratings
4 analystsNumber of analysts at each rating.
IMNN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
IMNN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.55 | −$0.71 | −$0.45 | −$1.16 | +52.6% | 4 |
| Current fiscal year (2026) | −$2.33 | −$2.89 | −$1.74 | −$6.83 | +65.8% | 4 |
| Next fiscal year (2027) | −$1.77 | −$3.03 | −$1.06 | −$2.33 | +24.1% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
IMNN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 4 |
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 4 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 4 |
IMNN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
IMNN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.60 | −$0.70 | −$0.55 | −$0.55 | −$0.55 | −9.1% | 2 up · 0 down |
| Current fiscal year (2026) | −$2.52 | −$3.01 | −$2.33 | −$2.33 | −$2.33 | −7.5% | 1 up · 1 down |
| Next fiscal year (2027) | −$2.18 | −$2.18 | −$1.77 | −$1.77 | −$1.77 | −18.8% | 3 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
IMNN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; IMNN beat in 11 of 12.
What analysts expect from IMNN
4 analysts cover Imunon; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $17.00, 1,566.7% above the latest close of $1.02. Analysts expect earnings of −$2.33 per share for 2026, +65.8% from a year earlier. For 2027 the average estimate is −$1.77 per share. Imunon beat the EPS estimate in 11 of the last 12 quarters.
Related: IMNN income statement, IMNN key metrics, IMNN chart. See the IMNN stock overview for the latest quote and news.
IMNN forecast FAQ
What is Imunon's price target?
The average analyst price target for Imunon is $17.00, 1,566.7% above the latest close of $1.02.
Is Imunon a buy, hold or sell?
Of 4 analysts covering Imunon, 3 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Imunon's EPS forecast?
Analysts forecast −$2.33 per share for 2026 (range −$2.89 to −$1.74); for 2027 the estimate is −$1.77.
When does Imunon report earnings?
Imunon is expected to report results for the quarter ending September 30, 2026 on November 12, 2026; the EPS estimate is $-0.61.
Does Imunon usually beat earnings estimates?
Imunon reported EPS at or above the analyst estimate in 11 of the last 12 quarters.